Table 2 Anthropometry, lab values and concomitant medication at baseline and week 38, median (range)
Baseline | Week 38 | |
|---|---|---|
Weight, kg (z score for age) | ||
Crohn’s disease (CD) | 44.4 (1.05) | 48 (1.26) |
Ulcerative colitis (UC) | 34.3 (1.36) | 44 (1.86) |
Height, cm | ||
CD | 164.0 (138–172) | 164.2 (140–172) |
UC | 146 (127–155) | 148 (130–155.5) |
Haemoglobin, g/dl | ||
CD | 8.4 (6.9–13.0) | 10.5 (7.8–12.3) |
UC | 10.4 (8.0–12,3) | 12.1 (8.0–14.8) |
Haematocrit, % | ||
CD | 26.2 (22.9–40.1) | 32.7 (25–38.3) |
UC | 29.6 (25.0–37.0) | 35.8 (25–41.1) |
Albumin, g/l | ||
CD | 29.6 (18.0–37.5) | 35.0 (28.1–42.4) |
UC | 27.9 (25.6–41.0) | 40 (36.5–48.0) |
C- reactive protein, mg/dl | ||
CD | 4.0 (3.0–8.1) | 2.6 (1.7–4.56) |
UC | 1.1 (0.1–3.0) | 0.9 (0.1–2.6) |
fecal calprotectin, μg/g stool | ||
CD | not applicable (n/a) | n/a |
UC | 1482 (84–5910) | 187 (5–9750) |
Concomitant medication | ||
Corticosteroids | ||
CD, n | 4/6 | 4/6 |
dosage, milligram per kilogram bodyweight (mg/KG BW) | 0.25 (0.1–0.4) | 0.23 (0.1–0.4) |
UC, n | 4/5 | 1/5 |
dosage, mg/KG BW | 1 (0.5–1.5) | 0.2 |
Azathioprine | ||
CD, n | 2/6 | 2/6 |
UC, n | 1/5 | 1/5 |
Mesalazine | ||
CD, n | 2/6 | 2/6 |
UC, n | 0/5 | 1/5 |